UNIGE document Scientific Article
previous document  unige:110911  next document
add to browser collection
Title

Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers

Authors
Mercer, Louise K
Askling, Johan
Raaschou, Pauline
Dixon, William G
Dreyer, Lene
Hetland, Merete Lund
Strangfeld, Anja
Zink, Angela
show hidden authors show all authors [1 - 17]
Published in Annals of the Rheumatic Diseases. 2017, vol. 76, no. 2, p. 386-391
Abstract Some studies have reported a possible association between exposure to tumour necrosis factor (TNF) inhibitors and an increased risk of melanoma. The aim of this study was to investigate the incidence of invasive cutaneous melanomas in patients with rheumatoid arthritis (RA) treated with TNF inhibitors (TNFi), other biologic disease modifying drugs and non-biologic therapy.
Keywords Abatacept/therapeutic useAdultAgedAged, 80 and overAntibodies, Monoclonal, Humanized/therapeutic useAntirheumatic Agents/therapeutic useArthritis, Rheumatoid/drug therapyBiological Products/therapeutic useEurope/epidemiologyFemaleHumansIncidenceMaleMelanoma/epidemiologyMiddle AgedRegistriesRisk FactorsRituximab/therapeutic useSkin Neoplasms/epidemiologyTumor Necrosis Factor-alpha/antagonists & inhibitors
Identifiers
PMID: 27307502
Full text
Article (Published version) (705 Kb) - public document Free access
Structures
Research group Mécanisme de l'inflammation articulaire (44)
Citation
(ISO format)
MERCER, Louise K et al. Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers. In: Annals of the Rheumatic Diseases, 2017, vol. 76, n° 2, p. 386-391. https://archive-ouverte.unige.ch/unige:110911

111 hits

30 downloads

Update

Deposited on : 2018-11-16

Export document
Format :
Citation style :